advertisement
38
Showing records 1 to 25 | Display all abstracts from61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Lewis RA
British Journal of Ophthalmology 2016; 100: 339-344
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Tanihara H
JAMA ophthalmology 2015; 133: 755-761
61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Aihara M
Journal of Glaucoma 2016; 25: e610-e614
61156 Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study
Solebo AL
British Journal of Ophthalmology 2015; 99: 1471-1476
61624 Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study
Freedman SF
JAMA ophthalmology 2015; 133: 907-914
61035 Prevalence of Optic Disc Hemorrhage in Korea: The Korea National Health and Nutrition Examination Survey
Kim DW
Investigative Ophthalmology and Visual Science 2015; 56: 3666-3672
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Inoue T
JAMA ophthalmology 2015; 133: 755-761
61156 Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study
Russell-Eggitt I
British Journal of Ophthalmology 2015; 99: 1471-1476
61035 Prevalence of Optic Disc Hemorrhage in Korea: The Korea National Health and Nutrition Examination Survey
Kim YK
Investigative Ophthalmology and Visual Science 2015; 56: 3666-3672
61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Levy B
British Journal of Ophthalmology 2016; 100: 339-344
61624 Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study
Lynn MJ
JAMA ophthalmology 2015; 133: 907-914
61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Ikeda Y; Mizoue S
Journal of Glaucoma 2016; 25: e610-e614
61156 Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study
Cumberland PM
British Journal of Ophthalmology 2015; 99: 1471-1476
61035 Prevalence of Optic Disc Hemorrhage in Korea: The Korea National Health and Nutrition Examination Survey
Jeoung JW
Investigative Ophthalmology and Visual Science 2015; 56: 3666-3672
61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Ramirez N
British Journal of Ophthalmology 2016; 100: 339-344
61624 Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study
Beck AD
JAMA ophthalmology 2015; 133: 907-914
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Yamamoto T
JAMA ophthalmology 2015; 133: 755-761
61156 Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study
Rahi JS
British Journal of Ophthalmology 2015; 99: 1471-1476
61035 Prevalence of Optic Disc Hemorrhage in Korea: The Korea National Health and Nutrition Examination Survey
Kim DM
Investigative Ophthalmology and Visual Science 2015; 56: 3666-3672
61624 Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study
Bothun ED
JAMA ophthalmology 2015; 133: 907-914
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Kuwayama Y
JAMA ophthalmology 2015; 133: 755-761
61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
C Kopczynski C
British Journal of Ophthalmology 2016; 100: 339-344
61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Arakaki Y
Journal of Glaucoma 2016; 25: e610-e614
61156 Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study
British Journal of Ophthalmology 2015; 99: 1471-1476
61624 Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study
Örge FH
JAMA ophthalmology 2015; 133: 907-914
